In a rising stock market, all eyes are on the income statement. #-ad_banner-#But in a flat or falling market, the balance sheet moves into the spotlight. Investors want to know that their stocks that possess certifiable take-it-to-the-bank value. The recent drubbing among tech and biotech stocks brought this issue right to the fore. Many of these stocks traded for 10 or even 20 times tangible book value and had no floor in place when investors began to head for the exits. As Warren Buffett’s gurus, Benjamin Graham and David Dodd, explained eight decades ago, you can sleep well… Read More
In a rising stock market, all eyes are on the income statement. #-ad_banner-#But in a flat or falling market, the balance sheet moves into the spotlight. Investors want to know that their stocks that possess certifiable take-it-to-the-bank value. The recent drubbing among tech and biotech stocks brought this issue right to the fore. Many of these stocks traded for 10 or even 20 times tangible book value and had no floor in place when investors began to head for the exits. As Warren Buffett’s gurus, Benjamin Graham and David Dodd, explained eight decades ago, you can sleep well at night only if you own stocks that are valued at a lower price than the net assets on the balance sheet — what’s known as “below book.” Back in Graham and Dodd’s era, you could find many stocks sporting such value. These days, less than 10% of all U.S. stocks with a market value of at least $200 million trade below book. And the pool of stocks that trade at a very deep discount to book value is even smaller. A quick review of such stocks suggests that a few industries are especially cheap in relation to their hard… Read More